Faye M Johnson

12PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 21, 2026
Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-apoptotic Cell Death in Rb-deficient Cancer Cells.

|Jan 08, 2025
Targeted inhibition of Aurora kinase A promotes immune checkpoint inhibition efficacy in human papillomavirus-driven cancers.

Soma Ghosh, Madison P O'Hara, Pragya Sinha

|Nov 26, 2024
Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas.

Faye M Johnson, Madison P O'Hara, Lacin Yapindi

|Feb 14, 2024
Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis.

Brady J Anderson, Amy C Moreno, Yun Qing

|Sep 28, 2022
Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.

Pooja A Shah, Vaishnavi Sambandam, Anne M Fernandez

Pageof 2